Population Pharmacokinetics of Clinafloxacin in Healthy Volunteers and Patients with InfectionsExperience with Heterogeneous Pharmacokinetic Data

被引：0
|
作者：
Bill Frame
Jeffrey Koup
Raymond Miller
Richard Lalonde
机构：
[1] PfizerGlobal Research and Development,Department of Clinical Pharmacokinetics and Pharmacodynamics
来源：
Clinical Pharmacokinetics | 2001年 / 40卷
关键词：
Mixed Effect Modelling; Interindividual Variability; Intraindividual Variability; Clinafloxacin; Combine Phase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: Clinafloxacin is a new fluoroquinolone antibacterial with inhibitory activity against aerobic, anaerobic and atypical bacterial pathogens. The objectives of this study are to evaluate the pharmacokinetics of clinafloxacin in healthy volunteers and patients with infections and to describe our experience with mixed-effects modelling using heterogeneous pharmacokinetic data.
引用
收藏
页码：307 / 315
页数：8
相关论文
共 50 条
  • [21] Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach
    Borghardt, Jens Markus
    Weber, Benjamin
    Staab, Alexander
    Kunz, Christina
    Formella, Stephan
    Kloft, Charlotte
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (03) : 538 - 552
  • [22] Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria
    Klein, Kerenaftali
    Aarons, Leon
    ter Kuile, Feiko O.
    Nosten, Francois
    White, Nick J.
    Edstein, Michael D.
    Teja-Isavadharm, Paktiya
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (11) : 1603 - 1613
  • [23] Comparable Population Pharmacokinetics of Cefadroxil in Cystic Fibrosis Patients and Healthy Volunteers
    Sutaria, Dhruvitkumar S.
    Jiao, Yuanyuan
    Tao, Xun
    Stephan, Ulrich
    Kinzig, Martina
    Soergel, Fritz
    Bulitta, Jiirgen B.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S22 - S22
  • [24] Population pharmacokinetics of eniporide and its metabolite in healthy volunteers and patients.
    Derendorf, H
    Bhattaram, VA
    Boettcher, S
    Dasenbrock, J
    Machnig, T
    Peters, T
    Kovar, A
    Nagaraja, NV
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P66 - P66
  • [25] Population pharmacokinetics of olprinone in healthy male volunteers
    Kunisawa, Takayuki
    Kasai, Hidefumi
    Suda, Makoto
    Yoshimura, Manabu
    Sugawara, Ami
    Izumi, Yuki
    Iida, Takafumi
    Kurosawa, Atsushi
    Iwasaki, Hiroshi
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2014, 6 : 43 - 50
  • [26] POPULATION PHARMACOKINETICS OF ARTESUNATE AND DIHYDROARTEMISININ IN HEALTHY VOLUNTEERS
    Tan, B.
    Fleckenstein, L.
    Yu, K. S.
    Jang, I. J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 135 - 135
  • [27] Population pharmacokinetics and pharmacogenetics of tyramine in healthy volunteers
    Rafehi, M.
    Faltraco, F.
    Matthaei, J.
    Prukop, T.
    Tzvetkov, M. V.
    Brockmoeller, J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S57 - S57
  • [28] Population pharmacokinetics of fentanyl in healthy volunteers.
    Ariano, RE
    Duke, P
    Sitar, DS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 153 - 153
  • [29] A population pharmacokinetic model of cabozantinib in healthy volunteers and patients with various cancer types
    Lacy, Steven
    Yang, Bei
    Nielsen, Jace
    Miles, Dale
    Linh Nguyen
    Hutmacher, Matt
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (06) : 1071 - 1082
  • [30] A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients
    Yan-xia Lu
    Qing-hong Su
    Ke-hua Wu
    Yu-peng Ren
    Liang Li
    Tian-yan Zhou
    Wei Lu
    Acta Pharmacologica Sinica, 2015, 36 : 281 - 288
12345